Switch theme
Sign up to access all valuation multiples
Eco Animal Health Group PLC is engaged in manufacturing and marketing animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The company's geographical segments include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World. Maximum revenue for the company is generated from China and Japan.
1984
222
LTM Revenue $110M
LTM EBITDA $9.3M
$27.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Eco Animal Health Group has a last 12-month revenue of $110M and a last 12-month EBITDA of $9.3M.
In the most recent fiscal year, Eco Animal Health Group achieved revenue of $115M and an EBITDA of $8.4M.
Eco Animal Health Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Eco Animal Health Group valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $110M | $115M | XXX | XXX | XXX |
| Gross Profit | $45.2M | $49.4M | XXX | XXX | XXX |
| Gross Margin | 41% | 43% | XXX | XXX | XXX |
| EBITDA | $9.6M | $8.4M | XXX | XXX | XXX |
| EBITDA Margin | 9% | 7% | XXX | XXX | XXX |
| Net Profit | -$0.9M | $1.3M | XXX | XXX | XXX |
| Net Margin | -1% | 1% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Eco Animal Health Group's stock price is GBP 1 (or $1).
Eco Animal Health Group has current market cap of GBP 35.6M (or $45.8M), and EV of GBP 20.9M (or $27.0M).
See Eco Animal Health Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $27.0M | $45.8M | XXX | XXX | XXX | XXX | $0.02 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Eco Animal Health Group has market cap of $45.8M and EV of $27.0M.
Eco Animal Health Group's trades at 0.2x LTM EV/Revenue multiple, and 2.9x LTM EBITDA.
Analysts estimate Eco Animal Health Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Eco Animal Health Group and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $27.0M | XXX | XXX | XXX |
| EV/Revenue | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | 3.0x | XXX | XXX | XXX |
| P/E | 22.6x | XXX | XXX | XXX |
| P/E/Growth | 0.7x | XXX | XXX | XXX |
| EV/FCF | 16.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpEco Animal Health Group's NTM/LTM revenue growth is 3%
Eco Animal Health Group's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Eco Animal Health Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Eco Animal Health Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Eco Animal Health Group and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -12% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 12% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.5M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 33% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 37% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Eco Animal Health Group acquired XXX companies to date.
Last acquisition by Eco Animal Health Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Eco Animal Health Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Eco Animal Health Group founded? | Eco Animal Health Group was founded in 1984. |
| Where is Eco Animal Health Group headquartered? | Eco Animal Health Group is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Eco Animal Health Group have? | As of today, Eco Animal Health Group has 222 employees. |
| Who is the CEO of Eco Animal Health Group? | Eco Animal Health Group's CEO is Mr. David Charles Hallas. |
| Is Eco Animal Health Group publicy listed? | Yes, Eco Animal Health Group is a public company listed on LON. |
| What is the stock symbol of Eco Animal Health Group? | Eco Animal Health Group trades under EAH ticker. |
| When did Eco Animal Health Group go public? | Eco Animal Health Group went public in 1995. |
| Who are competitors of Eco Animal Health Group? | Similar companies to Eco Animal Health Group include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Eco Animal Health Group? | Eco Animal Health Group's current market cap is $45.8M |
| What is the current revenue of Eco Animal Health Group? | Eco Animal Health Group's last 12-month revenue is $110M. |
| What is the current EBITDA of Eco Animal Health Group? | Eco Animal Health Group's last 12-month EBITDA is $9.3M. |
| What is the current EV/Revenue multiple of Eco Animal Health Group? | Current revenue multiple of Eco Animal Health Group is 0.2x. |
| What is the current EV/EBITDA multiple of Eco Animal Health Group? | Current EBITDA multiple of Eco Animal Health Group is 2.9x. |
| What is the current revenue growth of Eco Animal Health Group? | Eco Animal Health Group revenue growth between 2023 and 2024 was 5%. |
| Is Eco Animal Health Group profitable? | Yes, Eco Animal Health Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
